To assess the time-dependent anti-tumor effects of 100 μM CBD, HCT116 and HT29 cells underwent treatment for 0, 8, 16, and 24 h, followed by analysis using LDH, caspase-3 activity, and WST-1 assays. Here, CASP3 is linked to neoplasm.